To further explore the relationships between serum IGF-1 levels and PD disease progression and severity, we analyzed the differences in IGF-1 levels in patients in different H-Y stages, and the results showed that serum IGF-1 levels in early-stage PD were significantly higher than those in the middle/late stages. This evidence concerns the gene IGF1 and Parkinson disease.